GSK Sales Get Boost From Specialty Medicines - 𝓤𝓷𝓲𝓽𝓮𝓭 𝓢𝓽𝓪𝓽𝓮 24

The U.K. drugmaker’s strength in the segment allowed it to offset a declining vaccines revenue and a flat performance in general medicines.

Categories